IJERPH, Vol. 16, Pages 2255: Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis
Conclusions. This scientometric analysis represents comprehensive evidence on the popularity and change in prospects of biological treatments for MDD from 1988 to 2017. The popularity of SSRI peaked between 1998 and 2002, when their efficacy, tolerability and safety profile allowed them to replace the TCAs and MAOIs. While the newer neurostimulation therapies are gaining momentum, the popularity of ECT has sustained.
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Bach X. Tran Giang H. Ha Giang T. Vu Long H. Nguyen Carl A. Latkin Kalpana Nathan Roger S. McIntyre Cyrus S. Ho Wilson W. Tam Roger C. Ho Tags: Article Source Type: research
More News: Amitriptyline | Brain | Bupropion | Celexa | Citalopram | Conferences | Cymbalta | Deep Brain Stimulation | Depression | Effexor | Electroconvulsive Therapy | Environmental Health | Fluoxetine | International Medicine & Public Health | Lexapro | Mirtazapine | Neurology | Neuroscience | Nortriptyline | Paroxetine | Paxil | Pristiq | Prozac | Psychiatry | Science | Sertraline | Study | Trazodone | Vagus Nerve Stimulation Therapy | Websites | Wellbutrin | Zoloft